Home  >  Products  >  SARS2 (seryl-tRNA synthetase 2, mitochondrial ) Blocking Peptide (the N terminal of SARS2)(100ug)
SARS2 (seryl-tRNA synthetase 2, mitochondrial ) Blocking Peptide (the N terminal of SARS2)(100ug)

SARS2 (seryl-tRNA synthetase 2, mitochondrial ) Blocking Peptide (the N terminal of SARS2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SARS2 Antibody (ARP62708_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62708
Size: 100ug
Weight: 57kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes the mitochondrial seryl-tRNA synthethase precursor, a member of the class II tRNA synthetase family. The mature enzyme catalyzes the ligation of Serine to tRNA(Ser) and participates in the biosynthesis of selenocysteinyl-tRNA(sec) in mitochondria. The enzyme contains an N-terminal tRNA binding domain and a core catalytic domain. It functions in a homodimeric form, which is stabilized by tRNA binding. This gene is regulated by a bidirectional promoter that also controls the expression of mitochondrial ribosomal protein S12. Both genes are within the critical interval for the autosomal dominant deafness locus DFNA4 and might be linked to this disease.
Alternative names: FLJ20450; SARS; SARSM; SERS; SYS; SerRSmt; mtSerRS
See Full Product Listings >